1-ChloroMethyl-4-n-octylbenzene
- $48.3 - $998
- Product name: 1-ChloroMethyl-4-n-octylbenzene
- CAS: 40016-26-0
- MF: C15H23Cl
- MW: 238.8
- EINECS:
- MDL Number:MFCD12923001
- Synonyms:1-ChloroMethyl-4-n-octylbenzene, 96%;p-Octylbenzyl chloride;1-(Chloromethyl)-4-octylbenzene;4-Octylbenzyl chloride;Benzene, 1-(chloromethyl)-4-octyl-
4 prices
Selected condition:
Brand
- AK Scientific
- Alfa Aesar
- American Custom Chemicals Corporation
Package
- 5MG
- 250mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number4365CT
- Product description1-(Chloromethyl)-4-octylbenzene
- Packaging5g
- Price$998
- Updated2021-12-16
- Buy
- ManufacturerAlfa Aesar
- Product numberH33122
- Product description1-Chloromethyl-4-n-octylbenzene, 96%
- Packaging250mg
- Price$48.3
- Updated2021-12-16
- Buy
- ManufacturerAlfa Aesar
- Product numberH33122
- Product description1-Chloromethyl-4-n-octylbenzene, 96%
- Packaging1g
- Price$132
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0069232
- Product description1-(CHLOROMETHYL)-4-OCTYLBENZENE 95.00%
- Packaging5MG
- Price$500.29
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4365CT | 1-(Chloromethyl)-4-octylbenzene | 5g | $998 | 2021-12-16 | Buy |
Alfa Aesar | H33122 | 1-Chloromethyl-4-n-octylbenzene, 96% | 250mg | $48.3 | 2021-12-16 | Buy |
Alfa Aesar | H33122 | 1-Chloromethyl-4-n-octylbenzene, 96% | 1g | $132 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0069232 | 1-(CHLOROMETHYL)-4-OCTYLBENZENE 95.00% | 5MG | $500.29 | 2021-12-16 | Buy |
Properties
Boiling point :119-121 °C(Press: 1 Torr)
Density :0.959±0.06 g/cm3(Predicted)
Density :0.959±0.06 g/cm3(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | |||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|